The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
103814388 10381438 8 F 2014 20160906 20140813 20160912 PER US-PFIZER INC-2014225143 PFIZER 54.00 YR F Y 62.50000 KG 20160912 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
103814388 10381438 1 PS PRISTIQ EXTENDED-RELEASE DESVENLAFAXINE SUCCINATE 1 Oral 50 MG, 1X/DAY Y 21992 50 MG PROLONGED-RELEASE TABLET QD
103814388 10381438 2 SS PRISTIQ EXTENDED-RELEASE DESVENLAFAXINE SUCCINATE 1 Oral 100 MG, DAILY Y 21992 100 MG PROLONGED-RELEASE TABLET
103814388 10381438 3 SS PRISTIQ EXTENDED-RELEASE DESVENLAFAXINE SUCCINATE 1 Oral 50 MG, 2X/DAY (ONCE IN THE MORNING AND ONCE AT NIGHT) Y 21992 50 MG PROLONGED-RELEASE TABLET BID
103814388 10381438 4 SS PRISTIQ EXTENDED-RELEASE DESVENLAFAXINE SUCCINATE 1 Oral 100 MG, 1X/DAY (ONCE A DAY AT NIGHT ) Y 21992 100 MG PROLONGED-RELEASE TABLET QD
103814388 10381438 5 SS PRISTIQ EXTENDED-RELEASE DESVENLAFAXINE SUCCINATE 1 Oral 100 MG, ALTERNATE DAY Y 21992 100 MG PROLONGED-RELEASE TABLET QOD
103814388 10381438 6 SS PRISTIQ EXTENDED-RELEASE DESVENLAFAXINE SUCCINATE 1 Oral UNK Y 21992 PROLONGED-RELEASE TABLET
103814388 10381438 7 C ALBUTEROL. ALBUTEROL 1 Respiratory (inhalation) UNK, AS NEEDED 0
103814388 10381438 8 C SINGULAIR MONTELUKAST SODIUM 1 50 MG, 1X/DAY 0 50 MG QD
103814388 10381438 9 C PROTONIX PANTOPRAZOLE SODIUM 1 50 MG, 1X/DAY 0 50 MG QD
103814388 10381438 10 C LORAZEPAM. LORAZEPAM 1 1 MG, 2X/DAY 0 1 MG BID
103814388 10381438 11 C TEMAZEPAM. TEMAZEPAM 1 30 MG, 1X/DAY AT BEDTIME (QHS) 0 30 MG QD
103814388 10381438 12 C EPIPEN EPINEPHRINE 1 UNK, AS NEEDED 0
103814388 10381438 13 C OXYCODONE OXYCODONE 1 UNK 0
103814388 10381438 14 C PHENERGAN PROMETHAZINE HYDROCHLORIDE 1 UNK 0
103814388 10381438 15 C PREVACID LANSOPRAZOLE 1 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
103814388 10381438 1 Depression
103814388 10381438 2 Anxiety
103814388 10381438 10 Anxiety
103814388 10381438 11 Insomnia
103814388 10381438 12 Rhinitis allergic

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
103814388 10381438 Anxiety
103814388 10381438 Coordination abnormal
103814388 10381438 Crying
103814388 10381438 Depressed mood
103814388 10381438 Drug intolerance
103814388 10381438 Drug prescribing error
103814388 10381438 Fatigue
103814388 10381438 Feeling abnormal
103814388 10381438 Nausea

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
103814388 10381438 1 2012 0
103814388 10381438 2 20140310 201406 0
103814388 10381438 3 201406 20140716 0
103814388 10381438 4 20140716 20140812 0
103814388 10381438 5 20140813 0
103814388 10381438 6 201510 0
103814388 10381438 10 20140116 0
103814388 10381438 11 20140116 0